INTERCEPT PHARMACEUTICALS IN's ticker is ICPT and the CUSIP is 45845P108. A total of 160 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q3 2022. The put-call ratio across all filers is 0.59 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,656,774 | +65.2% | 197,237 | -1.4% | 0.07% | +78.9% |
| Q2 2023 | $2,213,316 | -21.1% | 200,119 | -4.2% | 0.04% | -33.3% |
| Q1 2023 | $2,804,171 | +9.4% | 208,799 | +0.7% | 0.06% | +1.8% |
| Q4 2022 | $2,563,967 | -13.5% | 207,273 | -2.5% | 0.06% | -17.6% |
| Q3 2022 | $2,965,000 | +88.7% | 212,548 | +86.8% | 0.07% | +100.0% |
| Q2 2022 | $1,571,000 | -15.7% | 113,770 | -0.6% | 0.03% | +3.0% |
| Q1 2022 | $1,863,000 | -3.6% | 114,494 | -3.5% | 0.03% | 0.0% |
| Q4 2021 | $1,932,000 | +7.7% | 118,604 | -1.8% | 0.03% | 0.0% |
| Q3 2021 | $1,794,000 | -27.0% | 120,805 | -1.8% | 0.03% | -25.0% |
| Q2 2021 | $2,456,000 | -11.5% | 122,960 | +2.3% | 0.04% | -17.0% |
| Q1 2021 | $2,775,000 | -16.1% | 120,218 | -10.2% | 0.05% | -20.9% |
| Q4 2020 | $3,306,000 | -44.1% | 133,828 | -6.2% | 0.07% | -52.1% |
| Q3 2020 | $5,913,000 | -16.5% | 142,612 | -3.5% | 0.14% | -20.0% |
| Q2 2020 | $7,083,000 | -25.2% | 147,832 | -1.7% | 0.18% | -39.2% |
| Q1 2020 | $9,470,000 | -56.2% | 150,412 | -13.7% | 0.29% | -39.1% |
| Q4 2019 | $21,598,000 | +70.2% | 174,293 | -8.8% | 0.47% | +58.2% |
| Q3 2019 | $12,687,000 | +22.8% | 191,188 | +47.3% | 0.30% | +23.6% |
| Q2 2019 | $10,329,000 | -35.1% | 129,815 | -8.7% | 0.24% | -32.6% |
| Q1 2019 | $15,905,000 | +7.9% | 142,188 | -2.8% | 0.36% | -5.8% |
| Q4 2018 | $14,742,000 | -23.9% | 146,268 | -4.6% | 0.38% | -5.2% |
| Q3 2018 | $19,378,000 | +30.0% | 153,358 | -13.7% | 0.40% | +30.9% |
| Q2 2018 | $14,905,000 | +17.4% | 177,635 | -13.9% | 0.31% | +23.3% |
| Q1 2018 | $12,700,000 | +1.0% | 206,430 | -4.1% | 0.25% | +2.9% |
| Q4 2017 | $12,577,000 | – | 215,290 | – | 0.24% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 640,688 | $9,514,000 | 1.49% |
| CM Management, LLC | 45,000 | $668,000 | 0.50% |
| EULAV Asset Management | 660,000 | $9,801,000 | 0.26% |
| DLD Asset Management, LP | 225,200 | $3,346,000 | 0.24% |
| Virtus ETF Advisers LLC | 21,387 | $318,000 | 0.14% |
| GSA CAPITAL PARTNERS LLP | 79,145 | $1,175,000 | 0.12% |
| Hennion & Walsh Asset Management, Inc. | 136,720 | $2,030,000 | 0.11% |
| ALTRINSIC GLOBAL ADVISORS LLC | 168,800 | $2,507,000 | 0.08% |
| Inspire Investing, LLC | 31,868 | $473,000 | 0.06% |
| DUALITY ADVISERS, LP | 51,196 | $760,000 | 0.06% |